James Li (JW)
Teamed up with Lyell, Juno/WuXi joint venture files IPO betting on China's CAR-T future
JW Therapeutics got its start on the back of CAR-T tech from Juno Therapeutics, a joint venture banking on the promise of marrying cutting-edge American …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.